Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase
about
Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cellsIsolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. Detection and identification of transglutaminase gene products based on reverse transcription-polymerase chain reaction with degenerate primersTwo new loci for autosomal recessive ichthyosis on chromosomes 3p21 and 19p12-q12 and evidence for further genetic heterogeneity.Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genesEvolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase ZGenetic disruption of the copulatory plug in mice leads to severely reduced fertilityLocalization of the transglutaminase cross-linking site in SVS III, a novel glycoprotein secreted from mouse seminal vesicleMassively parallel sequencing of human urinary exosome/microvesicle RNA reveals a predominance of non-coding RNA.Aminopeptidase activities as prospective urinary biomarkers for bladder cancer.Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer.Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.Human prostate cancer risk factors.Retinoic acid and androgen receptors combine to achieve tissue specific control of human prostatic transglutaminase expression: a novel regulatory network with broader significance.Spermatozoa protein alterations in infertile men with bilateral varicoceleTransglutaminases and their substrates in biology and human diseases: 50 years of growing.Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.Overexpression of transglutaminase 4 and prostate cancer progression: a potential predictor of less favourable outcomes.Synergic effect of α-tocopherol and naringenin in transglutaminase-induced differentiation of human prostate cancer cells.Prostate transglutaminase: a unique transglutaminase and its role in prostate cancer.Evidences for a role of protein cross-links in transglutaminase-related disease.Transglutaminase 4 as a prostate autoantigen in male subfertility.Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21.Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene.Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2.Androgen-dependent expression, gene structure, and molecular evolution of guinea pig caltrin II, a WAP-motif protein.Identification, evolution, and regulation of expression of Guinea pig trappin with an unusually long transglutaminase substrate domain.
P2860
Q21245730-8D15E8C8-C714-4ADE-8BAA-6C0C2B6FA23BQ24329161-628C7F9F-4663-4754-81BC-63C5A67C1A8EQ24539094-FE79348C-F027-47E2-82B7-C5A43CEF6531Q24622260-A6A3CAB5-EB4D-4825-98D9-FCC85793F57DQ28199362-7649359A-3D37-4730-AFF7-3B6192E6673FQ28511399-2CA7A0CB-1349-4B0F-99E8-85A96CD92214Q28594593-32EEFE13-9E0F-49A1-B7A3-D90FBAD68DFEQ33590048-2C93F563-B37A-4FA7-A00C-F6D1FCD6C839Q33762931-C2B1839A-6F85-4DCE-9E38-AB190EDC67A9Q33809160-7DBB6660-C752-4295-8B85-2E74E7E506C6Q33926887-81833BAE-6067-4CA2-9BE4-835FAB94587CQ34360616-363072AF-22B1-401E-9699-AB296CB1E734Q36008112-455CFDB6-03E9-42CE-9F43-3C37C6CDBF78Q36530237-C0C47717-5AF5-42DA-9A87-6362C0B63898Q37205858-E16E67CB-5F69-4F82-9331-2AF0962809CEQ37266151-F3C96FA6-F207-40A4-8F96-3EFE07E16AFEQ37370501-045A4F42-C4FA-465A-A893-485D85377CCDQ37803548-CBB494BA-91A0-499E-8E9D-1D3482F44B93Q37886988-CA859E2D-998F-44A6-926F-B6B276757E62Q37907975-C2041E1F-4C89-49EF-A4B2-6CA04C55ACECQ38389086-9118C5F3-D820-40FA-B638-4160B89FE800Q39370002-7FA2E1ED-FFD7-471B-A19C-5DD4658A2957Q40272344-8C68AE28-E2AA-423D-90CF-844D18267778Q40855647-C21240B1-47AE-4790-B895-CD16A68C4D3AQ41791459-1DDF32CE-86C2-4457-9AB1-5A007953F9C2Q44968579-8BD28718-9E0B-4D45-8696-7F3E9AF13EE4Q48145809-8C0228F1-DC6B-468C-A803-3A96CFD2C85A
P2860
Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Tissue specific and androgen-r ...... tate-specific transglutaminase
@ast
Tissue specific and androgen-r ...... tate-specific transglutaminase
@en
Tissue specific and androgen-r ...... tate-specific transglutaminase
@nl
type
label
Tissue specific and androgen-r ...... tate-specific transglutaminase
@ast
Tissue specific and androgen-r ...... tate-specific transglutaminase
@en
Tissue specific and androgen-r ...... tate-specific transglutaminase
@nl
prefLabel
Tissue specific and androgen-r ...... tate-specific transglutaminase
@ast
Tissue specific and androgen-r ...... tate-specific transglutaminase
@en
Tissue specific and androgen-r ...... tate-specific transglutaminase
@nl
P2093
P2860
P356
P1433
P1476
Tissue specific and androgen-r ...... tate-specific transglutaminase
@en
P2093
F H Schröder
H J Dubbink
J C Romijn
N S Verkaik
P2860
P356
10.1042/BJ3150901
P407
P478
315 ( Pt 3)
P577
1996-05-01T00:00:00Z